These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12702999)

  • 21. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ; Song B; Wu B; Xu J; Zhao LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma.
    Kongtawelert P; Tangkijvanich P; Ong-Chai S; Poovorawan Y
    World J Gastroenterol; 2003 Oct; 9(10):2178-81. PubMed ID: 14562373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of AFP-producing cholangiocarcinoma with difficulty in differential diagnosis from hepatocellular carcinoma].
    Omori J; Niimi A; Furuichi Y; Takeuchi E; Ishikawa T; Yanagisawa A; Ogihara S; Tsuchiya M; Misaka R; Shigemoto M; Kurihara T; Maeda A; Yamashita K; Aratake T; Kameoka S; Nishikawa T
    Nihon Shokakibyo Gakkai Zasshi; 2004 Oct; 101(10):1106-11. PubMed ID: 15529784
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.
    Loyer EM; Chin H; DuBrow RA; David CL; Eftekhari F; Charnsangavej C
    Radiology; 1999 Sep; 212(3):866-75. PubMed ID: 10478259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
    Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
    J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
    Sheng RF; Zeng MS; Rao SX; Ji Y; Chen LL
    Clin Imaging; 2014; 38(3):265-72. PubMed ID: 24559750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis.
    Tan W; He J; Deng J; Yang X; Cui L; Ran R; Du G; Jiang X
    Sci Rep; 2018 Feb; 8(1):3309. PubMed ID: 29459779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholangiolocellular carcinoma of the liver: CT and MR findings.
    Fukukura Y; Hamanoue M; Fujiyoshi F; Sasaki M; Haruta K; Inoue H; Aiko T; Nakajo M
    J Comput Assist Tomogr; 2000; 24(5):809-12. PubMed ID: 11045707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Tao LY; Cai L; He XD; Liu W; Qu Q
    Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.
    Saboo SS; Krajewski KM; Jagannathan JP; O'Regan KN; Odze R; Ramaiya N; Wolpin BM
    Cancer Imaging; 2011 Mar; 11(1):37-41. PubMed ID: 21507775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT; Hauss J
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helical CT assessment on hilar cholangiocarcinoma: comparison value of arterial phase and portovenous phase correlation.
    Aphinives C; Tumsatan P; Srinakarin J; Laopaiboon V; Aphinives P
    J Med Assoc Thai; 2007 Nov; 90(11):2403-8. PubMed ID: 18181327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
    Yamanaka N; Okamoto E; Ando T; Oriyama T; Fujimoto J; Furukawa K; Tanaka T; Tanaka W; Nishigami T
    Cancer; 1995 Dec; 76(12):2449-56. PubMed ID: 8625070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.